Bringing Open Science to Alzheimer’s and Dementia Clinical Trials
Raising the bar on data and biosample sharing from AD/ADRD clinical trials Laurie Ryan, Chief, Clinical Interventions and Diagnostics Branch, and Suzana Petanceska, Director, Office for Strategic Development and Partnerships, Division of NeuroscienceNIA’s increased funding for Alzheimer’s disease and related dementias (AD/ADRD) research has allowed the continued expansion and diversification of our drug development portfolio and […]
Bringing Open Science to Alzheimer’s and Dementia Clinical Trials Read More »